65 related articles for article (PubMed ID: 20881864)
21. Microcystic stromal tumor of the ovary: report of 16 cases of a hitherto uncharacterized distinctive ovarian neoplasm.
Irving JA; Young RH
Am J Surg Pathol; 2009 Mar; 33(3):367-75. PubMed ID: 18971779
[TBL] [Abstract][Full Text] [Related]
22. Hobnail-like cells in serous borderline tumor do not represent concomitant incipient clear cell neoplasms.
Ohishi Y; Oda Y; Kurihara S; Kaku T; Yasunaga M; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
Hum Pathol; 2009 Aug; 40(8):1168-75. PubMed ID: 19368953
[TBL] [Abstract][Full Text] [Related]
23. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
24. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance.
Murray SK; Young RH; Scully RE
Int J Gynecol Pathol; 2003 Oct; 22(4):324-33. PubMed ID: 14501811
[TBL] [Abstract][Full Text] [Related]
25. Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data.
Vang R; Shih IeM; Salani R; Sugar E; Ayhan A; Kurman RJ
Am J Surg Pathol; 2008 Nov; 32(11):1667-74. PubMed ID: 18769340
[TBL] [Abstract][Full Text] [Related]
26. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.
Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG
Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420
[TBL] [Abstract][Full Text] [Related]
28. Differences in tumor type in low-stage versus high-stage ovarian carcinomas.
Köbel M; Kalloger SE; Huntsman DG; Santos JL; Swenerton KD; Seidman JD; Gilks CB;
Int J Gynecol Pathol; 2010 May; 29(3):203-11. PubMed ID: 20407318
[TBL] [Abstract][Full Text] [Related]
29. Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations.
Kiyokawa T; Young RH; Scully RE
Am J Surg Pathol; 2006 Mar; 30(3):277-99. PubMed ID: 16538048
[TBL] [Abstract][Full Text] [Related]
30. Common epithelial tumors of the ovary: proliferating and of low malignant potential.
Ulbright TM; Roth LM
Semin Diagn Pathol; 1985 Feb; 2(1):2-15. PubMed ID: 2832916
[TBL] [Abstract][Full Text] [Related]
31. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
Bonome T; Lee JY; Park DC; Radonovich M; Pise-Masison C; Brady J; Gardner GJ; Hao K; Wong WH; Barrett JC; Lu KH; Sood AK; Gershenson DM; Mok SC; Birrer MJ
Cancer Res; 2005 Nov; 65(22):10602-12. PubMed ID: 16288054
[TBL] [Abstract][Full Text] [Related]
32. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
Gershenson DM; Sun CC; Bodurka D; Coleman RL; Lu KH; Sood AK; Deavers M; Malpica AL; Kavanagh JJ
Gynecol Oncol; 2009 Jul; 114(1):48-52. PubMed ID: 19361839
[TBL] [Abstract][Full Text] [Related]
33. Nuclear size distinguishes low- from high-grade ovarian serous carcinoma and predicts outcome.
Hsu CY; Kurman RJ; Vang R; Wang TL; Baak J; Shih IeM
Hum Pathol; 2005 Oct; 36(10):1049-54. PubMed ID: 16226103
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostic difficulties in serous "borderline" tumors of the ovary].
Vereczkey I; Tóth E; Orosz Z
Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323
[TBL] [Abstract][Full Text] [Related]
35. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors.
Ortiz BH; Ailawadi M; Colitti C; Muto MG; Deavers M; Silva EG; Berkowitz RS; Mok SC; Gershenson DM
Cancer Res; 2001 Oct; 61(19):7264-7. PubMed ID: 11585764
[TBL] [Abstract][Full Text] [Related]
36. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors.
Burks RT; Sherman ME; Kurman RJ
Am J Surg Pathol; 1996 Nov; 20(11):1319-30. PubMed ID: 8898836
[TBL] [Abstract][Full Text] [Related]
37. Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases.
DeLair D; Oliva E; Köbel M; Macias A; Gilks CB; Soslow RA
Am J Surg Pathol; 2011 Jan; 35(1):36-44. PubMed ID: 21164285
[TBL] [Abstract][Full Text] [Related]
38. Basal cell carcinoma of the prostate: a clinicopathologic study of 29 cases.
Ali TZ; Epstein JI
Am J Surg Pathol; 2007 May; 31(5):697-705. PubMed ID: 17460452
[TBL] [Abstract][Full Text] [Related]
39. Diffusely infiltrating endometrial carcinomas with no stromal response: report of a series, including cases with cervical and ovarian involvement and emphasis on the potential for misdiagnosis.
Kalyanasundaram K; Ganesan R; Perunovic B; McCluggage WG
Int J Surg Pathol; 2010 Apr; 18(2):138-43. PubMed ID: 19117974
[TBL] [Abstract][Full Text] [Related]
40. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
Zhao J; Epstein JI
Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
